XML 27 R18.htm IDEA: XBRL DOCUMENT v3.24.3
STOCKHOLDERS' EQUITY
9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
STOCKHOLDERS' EQUITY

NOTE 10 - STOCKHOLDERS' EQUITY

 

The Company is authorized to issue an aggregate of 12,000,000,000 common shares with a par value of $0.0001 per share and 1,000,000 shares of preferred stock with a par value of $0.0001 per share.

 

On August 22, 2023, pursuant to stockholder consent, our Board of Directors authorized an amendment (the "Amendment") to our Certificate of Incorporation, as amended, to effect a reverse stock split of the issued and outstanding shares of our common stock, par value $0.0001, on a 1 for 1,000 bases. We filed the Amendment with the Delaware Secretary of State on August 22, 2023. On September 21, 2023 the Financial Industry Regulatory Authority, Inc. notified us that the reverse stock split would take effect on September 29, 2023. All common stock share and per-share amounts for all periods presented in these consolidated financial statements have been adjusted retroactively to reflect the reverse stock split.

 

During the nine months ended September 30, 2024, the Company elected to convert $179,532 of principal and interest of non-redeemable convertible notes into 1,795,316,500 shares of common stock of the Company with a fair value of $821,094 resulting in a loss of extinguishment of debt of $641,562.

 

During the nine months ended September 30, 2024, the Company elected to settle $17,500 of principal and interest of promissory notes by issuing 175,000,000 shares of common stock of the Company with a fair value of $17,500.

 

On February 26, 2024, the Company agreed to issue 8,000,000 shares of common stock with a fair value of $109,600 to settle accrued salary and expenses of $296,000 (CAD $400,000) due to Nadav Elituv, the Chief Executive Officer of the Company resulting an increase in additional paid-in capital of $186,400.